The RIP1-Tag2 (RT2) mouse model of pancreatic neuroendocrine tumors (PNET)22 provides a well-studied in vivo platform in which to investigate the potential role of Egfr signaling in the stepwise progression of neoplastic lesions toward malignancy. Here, EGFR is linked to primitive neuroectodermal tumor.